XML 15 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
ASSETS      
Cash and cash equivalents $ 98,580,247 $ 98,478,202  
Investments 167,692,971 128,401,136  
Accounts receivable 33,233,682 17,805,864  
Prepaid expenses 2,661,426 2,977,759  
Income taxes receivable 0 256,538  
Property and equipment, net of accumulated depreciation 6,492,621 6,740,396  
Deferred taxes 8,083,072 8,437,446  
Total assets 316,744,019 263,097,341  
Liabilities      
Accounts payable and accrued expenses 10,572,810 8,002,303  
Accrued incentive compensation 28,830,744 28,400,000  
Income taxes payable 1,032,435   $ 0
Deferred compensation 34,883,646 33,241,952  
Total liabilities 75,319,635 69,644,255  
Redeemable noncontrolling interest 13,367,474 9,372,333  
Permanent Shareholders’ equity      
Common stock, no par value: 7,000,000 shares authorized; 3,172,252 issued and outstanding at September 30, 2021 (inclusive of 202,630 unvested shares); 3,168,823 issued and outstanding at December 31, 2020 (inclusive of 183,718 unvested shares) 80,555,674 80,810,946  
Preferred stock, undesignated, 1,000,000 shares authorized and unissued 0 0  
Deferred equity compensation (17,188,383) (14,748,118)  
Retained earnings 164,689,619 118,017,925  
Total permanent shareholders’ equity 228,056,910 184,080,753 $ 206,055,499
Total liabilities and shareholders’ equity $ 316,744,019 $ 263,097,341  
Book value per share (usd per share) $ 71.89 $ 58.09